Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
CLA3884 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A18888 | 26883384 | Sci Rep | Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis. | 2016 | Details |
| A18889 | 26883167 | Sci Rep | Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis. | 2016 | Details |
| A18907 | 26874844 | J Gastroenterol | A micro-RNA expression signature for human NAFLD progression. | 2016 | Details |
| A18913 | 26872443 | Nucl Med Biol | Staging of fibrosis in experimental non-alcoholic steatohepatitis by quantitative molecular imaging in rat models. | 2015 | Details |
| A18925 | 26868515 | Lipids Health Dis | Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats. | 2016 | Details |
| A18932 | 26861926 | Diabetes Care | Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes. | 2016 | Details |
| A18968 | 26844476 | Medicine (Baltimore) | Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines. | 2016 | Details |
| A18970 | 26843850 | Proteome Sci | Quantitative succinylome analysis in the liver of non-alcoholic fatty liver disease rat model. | 2016 | Details |
| A18991 | 26829441 | J Clin Endocrinol Metab | Impaired Insulin Suppression of VLDL-Triglyceride Kinetics in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A19004 | 26824361 | PLoS One | Association between Dietary Vitamin C Intake and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Middle-Aged and Older Adults. | 2016 | Details |
| A19016 | 26818542 | Hepatobiliary Pancreat Dis Int | Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey. | 2016 | Details |
| A19021 | 26815314 | Liver Int | Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease. | 2016 | Details |
| A19024 | 26814015 | Am J Physiol Endocrinol Metab | Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity. | 2016 | Details |
| A19027 | 26813130 | Zhonghua Yi Xue Za Zhi | [Relationship of visceral adiposity index with serum aminotransferase and nonalcoholic fatty liver disease in patients with sleep apnea]. | 2015 | Details |
| A19030 | 26812073 | J Hepatol | Type 2 diabetes and risk of hospital admission or death for chronic liver diseases. | 2016 | Details |
| A19037 | 26808140 | PLoS One | Continuous Grading of Early Fibrosis in NAFLD Using Label-Free Imaging: A Proof-of-Concept Study. | 2016 | Details |
| A19056 | 26796885 | World J Surg | Cholecystectomy Causes Ultrasound Evidence of Increased Hepatic Steatosis. | 2016 | Details |
| A19068 | 26785389 | Hepatol Res | The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment. | 2016 | Details |
| A19093 | 26770926 | Clin Mol Hepatol | Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study. | 2015 | Details |
| A19112 | 26756202 | Diabet Med | Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor -γ (PPARG) mutation, H449L: a comparison of people with this mutation and those with classic codon 482 Lamin A/C (LMNA) mutations. | 2016 | Details |
| A19113 | 26755885 | World J Gastroenterol | Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents. | 2016 | Details |
| A19150 | 26727365 | PLoS One | Efficacy of Dietary Lipid Control in Healing High-Fat and High-Cholesterol Diet-Induced Fibrotic Steatohepatitis in Rats. | 2016 | Details |
| A19153 | 26725908 | Liver Int | Iron and the liver. | 2016 | Details |
| A19169 | 30280553 | Eksp Klin Gastroenterol | [LIPID PROFILE AND LIVER DISEASES AMONG PATIENTS WITH MORBID OBESITY]. | 2018 | Details |
| A19191 | 28329615 | Dermatol Online J | Necrolytic migratory erythema associated with fatty liver disease and the psuedoglucagonoma syndrome. | 2016 | Details |
| A19193 | 26715612 | Lab Med | Selected Noninvasive Markers in Diagnosing Liver Diseases. | 2015 | Details |
| A19206 | 26703170 | J Med Ultrason (2001) | Hepatosteatosis and carotid intima-media thickness in patients with myocardial infarction. | 2015 | Details |
| A19211 | 26699443 | J Gastroenterol Hepatol | Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice. | 2016 | Details |
| A19214 | 26698665 | Free Radic Biol Med | Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development. | 2015 | Details |
| A19219 | 26697490 | Biomed Res Int | Quercetin Alleviates High-Fat Diet-Induced Oxidized Low-Density Lipoprotein Accumulation in the Liver: Implication for Autophagy Regulation. | 2015 | Details |
| A19236 | 26681372 | West Indian Med J | Partial Protection from Metabolic Syndrome in Chronic Hepatitis C Elderly Subjects Due to Lower Triglyceride Level. | 2015 | Details |
| A19237 | 26681076 | Physiol Res | Boldine attenuates cholestasis associated with nonalcoholic fatty liver disease in hereditary hypertriglyceridemic rats fed by high-sucrose diet. | 2015 | Details |
| A19241 | 26677985 | Gastroenterology | Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. | 2015 | Details |
| A19252 | 26672639 | J Clin Endocrinol Metab | Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies. | 2015 | Details |
| A19260 | 26668503 | World J Gastroenterol | Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease. | 2015 | Details |
| A19261 | 26667698 | Nutr Hosp | MEDITERRANEAN DIET IS ASSOCIATED WITH LIVER HISTOLOGY IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE. | 2015 | Details |
| A19275 | 26663004 | Hepatobiliary Pancreat Dis Int | Gut microbiota and non-alcoholic fatty liver disease. | 2015 | Details |
| A19316 | 26633474 | Nutrients | The Emerging Role of Disturbed CoQ Metabolism in Nonalcoholic Fatty Liver Disease Development and Progression. | 2015 | Details |
| A19332 | 26626496 | J Hepatol | Effects of glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic fatty liver disease. | 2015 | Details |
| A19341 | 26620139 | Semin Cardiothorac Vasc Anesth | Transfemoral Transcatheter Aortic Valve Replacement for Mixed Aortic Valve Disease in Child's Class C Liver Disease Prior to Orthotopic Liver Transplantation: A Case Report. | 2015 | Details |
| A19345 | 26618774 | PLoS One | A Prospective Study of Fatty Liver Index and Incident Hypertension: The KoGES-ARIRANG Study. | 2015 | Details |
| A19355 | 26610348 | Gut Liver | Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in Japan. | 2016 | Details |
| A19360 | 26608256 | Lancet | Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. | 2015 | Details |
| A19366 | 26602577 | P R Health Sci J | A Comparison of Brunt's Criteria, the Non-Alcoholic Fatty Liver Disease Activity Score (NAS), and a Proposed NAS Scoring that Includes Fibrosis in Non-Alcoholic Fatty Liver Disease Staging. | 2015 | Details |
| A19373 | 26600855 | Res Pharm Sci | Effects of rosuvastatin and/or β-carotene on non-alcoholic fatty liver in rats. | 2015 | Details |
| A19376 | 26600078 | Hepatology | The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. | 2016 | Details |
| A19377 | 26599819 | PLoS One | Lipoprotein Profiles in Class III Obese Caucasian and African American Women with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19408 | 26586275 | Prog Cardiovasc Dis | The Evidence for Saturated Fat and for Sugar Related to Coronary Heart Disease. | 2015 | Details |
| A19414 | 26581806 | Sci Rep | Beneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitis. | 2015 | Details |
| A19426 | 26573193 | Zhonghua Gan Zang Bing Za Zhi | [Relationship of socioeconomic status and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus]. | 2015 | Details |
| A19435 | 26571018 | PLoS One | High Dietary Sodium Intake Assessed by Estimated 24-h Urinary Sodium Excretion Is Associated with NAFLD and Hepatic Fibrosis. | 2015 | Details |
| A19448 | 26565781 | Popul Health Manag | Effects of Eating Fast and Eating Before Bedtime on the Development of Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19450 | 26564718 | Am J Physiol Gastrointest Liver Physiol | Podoplanin discriminates distinct stromal cell populations and a novel progenitor subset in the liver. | 2015 | Details |
| A19468 | 26547840 | BMC Complement Altern Med | Non-alcoholic fatty liver disease among sasang constitutional types: a population-based study in Korea. | 2015 | Details |
| A19476 | 26537487 | Dig Dis Sci | Development and Validation of an Algorithm to Identify Nonalcoholic Fatty Liver Disease in the Electronic Medical Record. | 2015 | Details |
| A19479 | 26536609 | J Magn Reson Imaging | MRI-determined liver proton density fat fraction, with MRS validation: Comparison of regions of interest sampling methods in patients with type 2 diabetes. | 2015 | Details |
| A19484 | 26528818 | PLoS One | Evaluation of Transient Elastography, Acoustic Radiation Force Impulse Imaging (ARFI), and Enhanced Liver Function (ELF) Score for Detection of Fibrosis in Morbidly Obese Patients. | 2015 | Details |
| A19522 | 26511621 | Cardiovasc Diabetol | Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk. | 2015 | Details |
| A19539 | 26500833 | Curr Hepatol Rep | Non-invasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet? | 2015 | Details |
| A19540 | 26500684 | Hepat Mon | Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma. | 2015 | Details |
| A19550 | 26494227 | Carcinogenesis | Connexin 32 and luteolin play protective roles in non-alcoholic steatohepatitis development and its related hepatocarcinogenesis in rats. | 2015 | Details |
| A19555 | 26487938 | J Gastrointest Oncol | Increased risk of colorectal polyps in patients with non-alcoholic fatty liver disease undergoing liver transplant evaluation. | 2015 | Details |
| A19561 | 26485523 | PLoS One | The Impact of PNPLA3 rs738409 Genetic Polymorphism and Weight Gain ≥10 kg after Age 20 on Non-Alcoholic Fatty Liver Disease in Non-Obese Japanese Individuals. | 2015 | Details |
| A19562 | 26485433 | PLoS One | 3,5 Diiodo-L-Thyronine (T2) Does Not Prevent Hepatic Steatosis or Insulin Resistance in Fat-Fed Sprague Dawley Rats. | 2015 | Details |
| A19616 | 26456168 | J Gastroenterol | Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey. | 2015 | Details |
| A19625 | 26449539 | BMC Genomics | The impact of PPARα activation on whole genome gene expression in human precision cut liver slices. | 2015 | Details |
| A19627 | 26448028 | Medicine (Baltimore) | Selective Estrogen Receptor Modulator-Associated Nonalcoholic Fatty Liver Disease Improved Survival in Patients With Breast Cancer: A Retrospective Cohort Analysis. | 2015 | Details |
| A19647 | 26438694 | Dis Model Mech | Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats. | 2015 | Details |
| A19650 | 26436447 | Liver Int | Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives. | 2015 | Details |
| A19653 | 26436351 | Ann Hepatol | Drug-induced fatty liver disease: An overview of pathogenesis and management. | 2016 | Details |
| A19659 | 26431876 | Biochem Biophys Res Commun | Hepatic scavenger receptor BI is associated with type 2 diabetes but unrelated to human and murine non-alcoholic fatty liver disease. | 2015 | Details |
| A19667 | 26426796 | Clin Transl Gastroenterol | Similar Reduction of Cholesterol-Adjusted Vitamin E Serum Levels in Simple Steatosis and Non-Alcoholic Steatohepatitis. | 2015 | Details |
| A19669 | 26425466 | Indian J Endocrinol Metab | Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes. | 2015 | Details |
| A19670 | 26424731 | Clin Sci (Lond) | Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease. | 2015 | Details |
| A19677 | 30538833 | Curr Health Sci J | Genetic Factors Involved in the Development and Progression of Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19685 | 26411937 | Nihon Eiseigaku Zasshi | [Mechanism Analysis and Prevention of Pathogenesis of Nonalcoholic Steatohepatitis]. | 2015 | Details |
| A19686 | 26410018 | Hum Pathol | Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study. | 2015 | Details |
| A19708 | 26401075 | World J Gastroenterol | Effects of salvianolic acid B on liver mitochondria of rats with nonalcoholic steatohepatitis. | 2015 | Details |
| A19713 | 26398456 | Eur J Gastroenterol Hepatol | Clinical and biochemical determinants of the extent of liver steatosis in type 2 diabetes mellitus. | 2015 | Details |
| A19719 | 26395746 | Int J Obes (Lond) | A novel cobiotic-based preventive approach against high-fat diet-induced adiposity, nonalcoholic fatty liver and gut derangement in mice. | 2015 | Details |
| A19727 | 26394161 | J Hepatol | Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis. | 2015 | Details |
| A19754 | 26378639 | Semin Liver Dis | Diagnosis and Assessment of NAFLD: Definitions and Histopathological Classification. | 2015 | Details |
| A19757 | 26377647 | Toxicol Sci | 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Alters Lipid Metabolism and Depletes Immune Cell Populations in the Jejunum of C57BL/6 Mice. | 2015 | Details |
| A19777 | 26356502 | PLoS One | Model-Based Quantification of the Systemic Interplay between Glucose and Fatty Acids in the Postprandial State. | 2015 | Details |
| A19783 | 26351523 | J Med Life | Medical nutrition therapy in non-alcoholic fatty liver disease--a review of literature. | 2016 | Details |
| A19784 | 26350282 | Abdom Imaging | Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults. | 2015 | Details |
| A19790 | 26347999 | Hepatol Res | Patatin-like phospholipase domain-containing protein 3 is involved in hepatic fatty acid and triglyceride metabolism through X-box binding protein 1 and modulation of endoplasmic reticulum stress in mice. | 2016 | Details |
| A19791 | 26347511 | Gut Liver | Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A19814 | 26330688 | Trans Am Clin Climatol Assoc | A Lipidomic Readout of Disease Progression in A Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19824 | 26325428 | Biochem Biophys Res Commun | Concerted action of p62 and Nrf2 protects cells from palmitic acid-induced lipotoxicity. | 2015 | Details |
| A19842 | 26314837 | J Gastroenterol | Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery. | 2015 | Details |
| A19845 | 26312773 | J Gastroenterol Hepatol | Effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatment. | 2016 | Details |
| A19851 | 26307979 | Int J Mol Sci | Docosahexaenoic Acid Levels in Blood and Metabolic Syndrome in Obese Children: Is There a Link? | 2015 | Details |
| A19862 | 26299811 | Toxicology | Protein tyrosine phosphatase 1B (PTP1B): A key regulator and therapeutic target in liver diseases. | 2015 | Details |
| A19877 | 26289793 | Sci Rep | Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis. | 2015 | Details |
| A19890 | 26281602 | Zhongguo Zhong Yao Za Zhi | [Intervention effect and mechanism of compound Ginkgo biloba preparations on nonalcoholic fatty liver]. | 2015 | Details |
| A19892 | 26281176 | Eksp Klin Gastroenterol | [ALLELES C282Y AND H63D HFE GENE, INSULIN RESISTANCE AND SUSCEPTIBILITY TO DISTURBANCE OF PORPHYRIN METABOLISM IN NON-ALCOHOLIC FATTY LIVER DISEASE]. | 2015 | Details |
| A19902 | 26274335 | Hepatology | Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. | 2015 | Details |
| A19916 | 26269698 | Case Rep Gastroenterol | Glycogenic Hepatopathy: Thinking Outside the Box. | 2015 | Details |
| A19929 | 26259026 | Liver Int | TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C. | 2015 | Details |